Virtue Capital Management, LLC Amgen Inc Transaction History

Virtue Capital Management, LLC

$477 Million
Q3 2024

A detailed history of Virtue Capital Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Virtue Capital Management, LLC holds 680 shares of AMGN stock, worth $200,280. This represents 0.05% of its overall portfolio holdings.

Number of Shares

680

Previous 868 21.66%

Holding current value

$200,280

Previous $271,000 19.19%

% of portfolio

0.05%

Previous 0.05%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 18, 2024	SELL	$309.38 - $337.38 $58,163 - $63,427	-188 Reduced 21.66%	680 $219,000
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $14,451 - $17,562	-55 Reduced 5.96%	868 $271,000
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $34,146 - $41,219	127 Added 15.95%	923 $262,000
Q4 2023 Feb 15, 2024	SELL	$255.7 - $288.46 $174,387 - $196,729	-682 Reduced 46.14%	796 $229,000
Q2 2023 Jul 18, 2023	BUY	$214.27 - $253.37 $106,920 - $126,431	499 Added 50.97%	1,478 $328,000
Q1 2023 May 11, 2023	SELL	$225.79 - $275.2 $677 - $825	-3 Reduced 0.31%	979 $236,000
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $7,328 - $9,312	-32 Reduced 3.16%	982 $257,000
Q3 2022 Nov 15, 2022	BUY	$224.46 - $253.15 $227,602 - $256,694	1,014 New	1,014 $228,000
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $1.04 Million - $1.22 Million	-4,903 Closed	0 $0
Q2 2021 Jul 15, 2021	SELL	$233.58 - $259.14 $41,343 - $45,867	-177 Reduced 3.48%	4,903 $1.2 Million
Q1 2021 May 13, 2021	SELL	$221.91 - $258.6 $361,269 - $421,000	-1,628 Reduced 24.27%	5,080 $1.26 Million
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $131,991 - $157,178	-610 Reduced 8.34%	6,708 $1.54 Million
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $62,182 - $69,151	265 Added 3.76%	7,318 $1.86 Million
Q2 2020 Aug 10, 2020	BUY	$197.81 - $242.74 $1.4 Million - $1.71 Million	7,053 New	7,053 $1.66 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $764,408 - $982,528	-4,040 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $149,560 - $179,204	-859 Reduced 17.53%	4,040 $782,000
Q2 2019 Nov 12, 2019	BUY	$166.7 - $195.41 $816,663 - $957,313	4,899 New	4,899 $903,000
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $242,184 - $272,995	-1,339 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$178.4 - $208.25 $1.24 Million - $1.44 Million	-6,935 Reduced 83.82%	1,339 $261,000
Q3 2018 Feb 13, 2019	BUY	$185.29 - $208.89 $720,407 - $812,164	3,888 Added 88.65%	8,274 $1.72 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $57,619 - $64,718	347 Added 8.59%	4,386 $810,000
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $13,215 - $15,444	-78 Reduced 1.89%	4,039 $705,000
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $694,908 - $776,425	4,117	4,117 $716,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtue Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtue Capital Management, LLC with notifications on news.

Account

Virtue Capital Management, LLC Amgen Inc Transaction History